CAPITAL FUND MANAGEMENT S.A.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1323645
PARIS, I0
Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,405,415
+$1,869,447 QoQ
Shares Held
73,219
+146.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#77
of 331 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPITAL FUND MANAGEMENT S.A. holds $95,675,665 across 11 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
53,037 | $28,737,037 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
568,912 | $19,724,179 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
98,117 | $16,536,639 | |
| 4 | ZTS |
Zoetis Inc.
|
150,407 | $10,808,247 | |
| 5 | HLN |
Haleon plc
|
1,054,437 | $9,837,897 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
73,219 | $3,405,415 | |
| 7 | ALKS |
Alkermes plc.
|
33,281 | $1,743,924 | |
| 8 | LQDA |
Liquidia Corp
|
20,491 | $1,633,747 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,405,415 | 73,219 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,535,968 | 29,715 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $1,114,845 | 23,328 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||